Skip to main content
. 2012 Oct 10;121(1):46–52. doi: 10.1289/ehp.1104816

Table 5.

Summary of studies examining the association between air quality measures and asthma.

Reference Data collection period Location Study population Sample size (n or no. studies) Outcomes Air quality measures Findings
Stieb et al. 2008 1981–2000 12 Canadian cities All ages NA Overall mortality AQHI, SO2, NO2, O3, CO, PM10, PM2.5 Each unit increase in AQHI was associated with an increase of 1.2% in mortality
Stieb et al. 2002 1985–2000 Worldwide All ages 109 studies All-cause, respiratory mortality SO2, NO2, O3, CO, PM10 Acute air pollution exposure was significantly associated with mortality; stronger associations with respiratory mortality for all pollutants except O3
Burnett et al. 1998 1980–1991 11 Canadian cities All ages 816,991 Mortality of nonaccidental causes SO2, NO2, O3, CO All pollutants were significantly associated with mortality; NO2 had the strongest association
Weinmayr et al. 2010 1990–2008 Europe, USA, other ≤ 18 years 36 studies LRS, cough, PEF of children with asthma NO2, PM10 PM10 was significantly associated with asthma symptom episode; NO2 was significantly associated with asthma symptoms in overall analysis only considering all possible lags
Stieb et al. 2009 1992–2003 7 Canadian cities All ages 83,563 (asthma); 125,145 (respiratory) ED visits for asthma and respiratory infection SO2, NO2, O3, CO, PM10, PM2.5 Ozone was associated with visits for respiratory conditions; PM2.5 and PM10 were associated with asthma visits in warm season
Lin et al. 2005 1998–2001 Toronto, Canada ≤ 14 years 6,782 Hospitalization for respiratory infection SO2, NO2, O3, CO, PM10, PM2.5, PM10–2.5 All PM fractions and NO2 were significantly associated with hospital admissions for respiratory infections
Current study 2012 2003–2006 Province of Ontario, Canada All ages 1.5 million (asthma) Outpatient, ED visits AQHI, NO2, O3, PM2.5 AQHI was significantly associated with asthma morbidity on the current day and 1–2 days prior
Abbreviations: LRS, lower respiratory symptoms; NA, not available; PEF, peak expiratory flow; PM10–2.5, PM, with an aerodynamic diameter between 2.5 and 10 µm, coarse PM .